Assistant Professor, Medicine, UCSF School of Medicine
Rheumatology
Dr. Jinoos Yazdany, MD
|
|
Give Review
Dr. Jinoos Yazdany practices Rheumatology. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He received 2 awards: "Fellow" and "Fellow (FACR)". Jinoos Yazdany is also published. He has 77 publications published. The lastest publication: "Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System.' Jinoos Yazdany, MD is registered with Medicare.
Publications
- Factors associated with access to rheumatologists for Medicare patients.
- Who receives contraception counseling when starting new lupus medications? The potential roles of race, ethnicity, Disease activity, and quality of communication.
- Interactions between patients, providers, and health systems and technical quality of care.
- Using medicare data to understand health care value-reply.
- Use and spending on biologic disease-modifying anti-rheumatic drugs for rheumatoid Arthritis among U.S. Medicare beneficiaries.
- Sleep disturbance, depression, obesity, and physical inactivity explain a significant portion of fatigue in rheumatoid Arthritis.
- Muscle strength, muscle mass, and physical disability in women with Systemic lupus erythematosus.
- Efficiency gains for rheumatology consultation using a novel electronic referral system in a safety net health setting.
- Muscle strength predicts changes in physical function in women with Systemic lupus erythematosus.
- Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with Systemic lupus erythematosus.
- Thirty-day hospital readmissions in Systemic lupus erythematosus: predictors and hospital- and state-level variation.
- Infection is the leading cause of hospital mortality in patients with dermatomyositis/polymyositis: Data from a population-based study.
- Using Medicare Data to Understand Low-Value Health Care: The Case of Intra-articular Hyaluronic Acid Injections.
- Validity of a self-administered version of the brief index of lupus damage in a predominantly african american Systemic lupus erythematosus cohort.
- A168: Systemic lupus erythematosus in-hospital mortality risk across ages: a national estimate.
- Quality of care in Systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study.
- Receipt of glucocorticoid monotherapy among medicare beneficiaries with rheumatoid Arthritis.
- Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record.
- Rheumatoid Arthritis quality measures and radiographic progression.
- Longitudinal validation of the Brief Index of Lupus Damage (BILD).
- Quality of care for incident Lupus nephritis among medicaid beneficiaries in the united states.
- Measuring hospital quality using pediatric readmission and revisit rates.
- Patterns of disease-modifying anti-rheumatic drug use in rheumatoid Arthritis patients after 2002: A systematic review.
- Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question.
- Extraarticular manifestations of rheumatoid Arthritis in a multiethnic cohort of predominantly Hispanic and asian patients.
- Comment on "Identification of rheumatoid Arthritis patients using an administrative database: A veterans affairs study" by NG and coauthors.
- Gender differences in assessment of obesity in rheumatoid Arthritis.
- American College of Rheumatology guidelines for screening, treatment, and management of Lupus nephritis.
- Quality of Care in Systemic Lupus Erythematosus: Application of Quality Measures to Understand Gaps in Care.
- Physical activity, obesity, and cognitive impairment among women with Systemic lupus erythematosus.
- Healthcare quality in Systemic lupus erythematosus: using Donabedian's conceptual framework to understand what we know.
- Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System.
- Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE.
- Validity of brief screening tools for cognitive impairment in RA and SLE.
- Quality measurement and improvement in rheumatology: Rheumatoid Arthritis as a case study.
- A longitudinal study of the impact of incident organ manifestations and increased Disease activity on work loss among persons with SLE.
- The impact of obesity on functioning among women with SLE.
- The Brief index of Lupus damage (BILD): A patient-reported measure of damage in SLE.
- Cardiovascular and Disease-related predictors of depression in systemic lupus erythematosus.
- Using the CES-D to screen for depression in SLE.
- Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid Arthritis in Medicare managed care plans.
- Contraceptive counseling and use among women with Systemic lupus erythematosus: A gap in health care quality?
- Drug monitoring in Systemic lupus erythematosus: a systematic review.
- Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurement.
- Obesity and its measurement in a community-based sample of women with Systemic lupus erythematosus.
- Systematic review of the literature informing the Systemic lupus erythematosus indicators project: reproductive health care quality indicators.
- Osteoporosis screening, prevention, and treatment in Systemic lupus erythematosus: application of the Systemic lupus erythematosus quality indicators.
- Role of community and individual characteristics in physician visits for persons with Systemic lupus erythematosus.
- Provision of preventive health care in Systemic lupus erythematosus: data from a large observational cohort study.
- Frequent use of the emergency department among persons with Systemic lupus erythematosus.
- Hydroxychloroquine treatment in a community-based cohort of patients with Systemic lupus erythematosus.
- Osteoporosis and cardiovascular Disease care in systemic lupus erythematosus according to new quality indicators.
- Childhood-onset Disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.
- Health-related quality of life and employment among persons with Systemic lupus erythematosus.
- Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?
- Bone health in Systemic lupus erythematosus.
- Clinical practice guidelines and diagnostic uncertainty in the management of early rheumatoid Arthritis.
- A quality indicator set for Systemic lupus erythematosus.
- Work loss and work entry among persons with Systemic lupus erythematosus: comparisons with a national matched sample.
- Depression, medication adherence, and service utilization in Systemic lupus erythematosus.
- Differences in long-term Disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.
- Health care costs and costs associated with changes in work productivity among persons with Systemic lupus erythematosus.
- Comment on "Quality indicators for psoriatic Arthritis".
- Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions.
- The role of neighborhood and individual socioeconomic status in outcomes of Systemic lupus erythematosus.
- Disability in valued life activities among individuals with Systemic lupus erythematosus.
- Quality of care in the rheumatic Diseases: current status and future directions.
- Validation of the Systemic lupus erythematosus activity questionnaire in a large observational cohort.
- Impact of memory impairment on employment status in persons with Systemic lupus erythematosus.
- Medicaid and access to care among persons with Systemic lupus erythematosus.
- Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in Systemic lupus erythematosus.
- Six refractory Lupus patients treated with rituximab: a case series.
- Impact of health maintenance organizations and fee-for-service on health care utilization among people with Systemic lupus erythematosus.
- Work dynamics among persons with Systemic lupus erythematosus.
- The role of CD40 ligand in Systemic lupus erythematosus.
- Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
Schools
University of California At Los Angeles
Procedures Preformed
- Joint Drainage
Conditions Treated
- Arthritis
- Bursitis
- Enthesopathy of Hip (incl. Trochanteric Bursitis)
- Giant Cell Arteritis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- CaliforniaCare HMO
- Blue Cross Blue Shield of California PPO
- Select Plus HMO
- Access Plus Savenet
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Delta Health System
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- WholeCare Network HMO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- PacifiCare HMO
- United Healthcare
Awards
- Fellow
- Fellow (FACR)
Education
-
UCSF -
David Geffen School of Medicine at UCLA
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1982632584 | |
| NPPES Provider LastName | YAZDANY | |
| NPPES Provider FirstName | JINOOS | |
| NPPES Provider ZIPCode | 941430326 | |
| NPPES Provider State | CA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 110.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982632584 |
| Last Name Of The Provider | YAZDANY |
| First Name Of The Provider | JINOOS |
| View All |
Similar Doctors
|
|
Dr. James A. Davis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy L. Carteron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Curtis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth E. Sack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerson C. Bernhard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Daikh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Davis Jr., MD |
|
|
Dr. Tamiko R. Katsumoto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Franziska G. Matzkies, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary C. Nakamura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Boris M. Peterlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lianne S. Gensler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger R. Wang, MD |
|
|
Dr. David Wofsy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ruth W. Chan, DO |